Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil
Open Access
- 1 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (3) , 363-369
- https://doi.org/10.1086/649843
Abstract
Background. In a Latin American trial, a monovalent G1P[8] rotavirus vaccine showed high efficacy against severe rotavirus diarrhea. Protection was lThis publication has 8 references indexed in Scilit:
- Live Attenuated Human Rotavirus Vaccine, RIX4414, Provides Clinical Protection in Infants Against Rotavirus Strains With and Without Shared G and P GenotypesThe Pediatric Infectious Disease Journal, 2009
- Rotarix: A Rotavirus Vaccine for the WorldClinical Infectious Diseases, 2009
- Rotavirus genotypes circulating in Brazil before national rotavirus vaccination: A reviewJournal of Clinical Virology, 2008
- Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccineArchiv für die gesamte Virusforschung, 2008
- Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccineReviews in Medical Virology, 2004
- Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimensJournal of Clinical Microbiology, 1990
- PROTECTIVE EFFECT OF NATURALLY ACQUIRED HOMOTYPIC AND HETEROTYPIC ROTAVIRUS ANTIBODIESPublished by Elsevier ,1986
- Retrospective assessment of the effectiveness of BCG vaccination against tuberculosis using the case-control methodTubercle, 1982